Tag Archives: phase

The battle over California redistricting enters new phase

The battle over California redistricting enters new phase

Facebook Tweet Email Link Sacramento, California  —  California Democrats may have successfully muscled a new congressional map through the state legislature this week, but the redistricting fight in the Golden State is only just beginning. With 74 days until the November vote, Gov. Gavin Newsom and his allies have a tight window to convince California voters to approve an extraordinary …

Read More »

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Study Achieves Primary and Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight with Once-Daily VK2735 Dosing as Compared to Placebo Up to 12.2% (26.6 lbs) Mean Weight Loss Observed After 13 Weeks of VK2735 Treatment Compared with 1.3% (2.9 lbs) for Placebo Exploratory Assessment of Low Dose Maintenance Treatment Demonstrates Positive Proof of Concept VK2735 Shown to be Safe …

Read More »

Eli Lilly and Company (LLY) Announces Results From LTE of Phase 3 TRAILBLAZER-ALZ 2 Study

Eli Lilly and Company (LLY) Announces Results From LTE of Phase 3 TRAILBLAZER-ALZ 2 Study

Eli Lilly and Company (NYSE:LLY) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On July 30, the company announced results from the long-term extension (LTE) of the Phase 3 TRAILBLAZER-ALZ 2 study, demonstrating that participants treated with Kisunla (donanemab-azbt) showcased slowing of decline, a benefit which continued to grow over 3 years as compared to an untreated external …

Read More »

Moon phase today explained: What the moon will look like on August 17, 2025

Moon phase today explained: What the moon will look like on August 17, 2025

The moon is slowly disappearing from view, and that’s because of where we are in the lunar cycle. What’s the lunar cycle, you ask? The lunar cycle is a series of eight unique phases of the moon’s visibility. The whole cycle takes about 29.5 days, according to NASA, and these different phases happen as the Sun lights up different parts …

Read More »

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s disease1  Ianalumab has the potential to become the first and only targeted treatment approved for patients with Sjögren’s disease Ianalumab was well tolerated and demonstrated a favorable safety profile in Sjögren’s …

Read More »

Pancreatic cancer vaccine prevents recurrence in Phase 1 clinical trial

Pancreatic cancer vaccine prevents recurrence in Phase 1 clinical trial

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back. Pancreatic cancer is of particular concern. The five-year survival rate is about 13%, and up to 80% of pancreatic cancers may come back. “If you were to ask me what disease most needs something to prevent recurrences, I’d say this one,” said Dr. …

Read More »

IO Biotech Melanoma Drug Shows 19.4-Month PFS in Phase 3 Trial Despite Statistical Miss

IO Biotech Melanoma Drug Shows 19.4-Month PFS in Phase 3 Trial Despite Statistical Miss

IO Biotech (NASDAQ: IOBT) announced topline results from its pivotal Phase 3 trial of Cylembio® plus KEYTRUDA® for first-line advanced melanoma treatment. While the combination showed clinical improvement in progression-free survival (19.4 months vs. 11.0 months), it narrowly missed statistical significance with HR=0.77 (p=0.056). Notable findings include a profound effect in PD-L1 …

Read More »

Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity – Eli Lilly and Company

Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity  Eli Lilly and Company Eli Lilly’s obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval  CNBC Lilly’s Obesity Pill Cut Body Weight by 11% in Key …

Read More »